beta-amyloid/alpha-synuclein/tau aggregation inhibitors (Snowdon)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta-amyloid/alpha-synuclein/tau aggregation inhibitors (Snowdon)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsMicrotubule-associated protein tau inhibitorsSynuclein alpha inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 proteinSynuclein alpha
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSnowdon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSnowdon
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A